Healthcare Value Capital’s Clovis Oncology, Inc. CLVS Stock Holding History

Healthcare Value Capital’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$2.23M	Hold	500,000	–	–	4.4%	12
2021 Q2	$2.9M	Buy	500,000 +50,000	+11%	+$293K	5.78%	8
2021 Q1	$3.16M	Buy	450,000 +200,000	+80%	+$1.34M	7.04%	4
2020 Q4	$1.2M	Hold	250,000	–	–	4.04%	11
2020 Q3	$1.46M	Hold	250,000	–	–	4.8%	9
2020 Q2	$1.69M	Hold	250,000	–	–	4.31%	11
2020 Q1	$1.59M	Buy	250,000 +100,000	+67%	+$802K	2.67%	17
2019 Q4	$1.56M	Sell	150,000 -100,000	-40%	-$727K	4.6%	9
2019 Q3	$983K	Buy	+250,000	New	+$2.02M	1.78%	16
2014 Q4	–	Sell	-25,000	Closed	-$1.13M	–	34
2014 Q3	$1.13M	Buy	+25,000	New	+$1.04M	1.09%	18

Other funds holding CLVS

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Healthcare Value Capital's CLVS Position: Q3 2021 in Review

Healthcare Value Capital held its Clovis Oncology, Inc. (CLVS) position steady in Q3 2021 at 500,000 shares worth $2.23M. The position accounts for 4.4% of the portfolio, ranked #12.

Healthcare Value Capital first reported a position in CLVS in Q3 2014 and has held it in 10 quarters since. The position peaked at $3.16M in Q1 2021. 158 funds tracked by Wall St. Rank hold CLVS as of Q3 2021.

Healthcare Value Capital held 500,000 shares of Clovis Oncology, Inc. worth $2.23M as of Q3 2021.
Healthcare Value Capital left its Clovis Oncology, Inc. share count unchanged in Q3 2021.
Clovis Oncology, Inc. made up 4.4% of Healthcare Value Capital's portfolio in Q3 2021, its #12 holding.
Healthcare Value Capital first reported a position in Clovis Oncology, Inc. in Q3 2014 and has held it in 10 quarters since.
Healthcare Value Capital's Clovis Oncology, Inc. position peaked at $3.16M in Q1 2021.
158 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.